Alangcas, Brenth Yael E.
HRN: 22-14-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2023
CEFUROXIME 750MG (VIAL)
04/22/2023
04/29/2023
IV
550
Q8h
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes